2 Stocks Every Investor Should Make Room in Their Portfolio For

NYSE: JNJ | Johnson & Johnson News, Ratings, and Charts

JNJ – Despite the October inflation report showing a slowdown in the price increases, the U.S. economy is still surrounded by deep uncertainty. Moreover, the IMF has warned of further challenges ahead. Therefore, quality stocks Johnson & Johnson (JNJ) and Coca-Cola (KO), which have a solid dividend-paying record, could be ideal additions to your portfolio. Keep reading….

Despite the October inflation report turning out better than expected, billionaire investor and Icahn Enterprises chairman Carl Icahn believes that stocks might tumble further in the near future. Moreover, rising recession odds are pretty concerning.

The International Monetary Fund sees a tough time ahead amid persistently high and broad-based inflation, weak growth momentum in China, and ongoing supply disruptions and food insecurity caused by Russia’s invasion of Ukraine.

“The challenges that the global economy is facing are immense, and weakening economic indicators point to further challenges ahead,” the IMF said.

Given the backdrop, investors could consider buying quality stocks, Johnson & Johnson (JNJ) and The Coca-Cola Company (KO), which boast solid dividend-paying records.

Johnson & Johnson (JNJ)

JNJ and its subsidiaries research, develop, manufacture, and sell various products in the healthcare field worldwide. Its segments are Consumer Health; Pharmaceutical; and MedTech.

On November 1, 2022, JNJ and Abiomed, Inc. (ABMD), a medical device technology company, announced their definitive agreement under which JNJ will acquire all outstanding shares of ABMD. This acquisition is expected to help JNJ enhance its Med-tech segment and make valuable contributions to cardiovascular treatment and therapy.

JNJ has paid dividends for 59 consecutive years. Its dividend payouts have increased at a 6% CAGR over the past five years. Its current dividend yield is 2.67%, and the four-year average yield is 2.60%.

JNJ’s sales came in at $23.79 billion for the 2022 third quarter, up marginally year-over-year. Its net earnings came in at $4.46 billion, up 21.6% year-over-year, while its EPS came in at $1.68, up 22.6% year-over-year.

For 2022, analysts expect JNJ’s revenue to increase marginally year-over-year to $95.04 billion. Its EPS is expected to increase by 3.9% per annum for the next five years. It surpassed EPS estimates in all four trailing quarters. Over the past month, the stock has gained 4% to close the last trading session at $169.25.

JNJ’s POWR Ratings reflect this promising outlook. The stock has an overall A rating, which equates to a Strong Buy in our POWR Rating system. The POWR Ratings assess stocks by 118 different factors, each with its weighting.

Also, the stock has an A grade for Stability and a B grade for Quality. Within the Medical – Pharmaceuticals industry, it is ranked #8 out of 162 stocks. Click here for the additional POWR Ratings for Growth, Value, Momentum, and Sentiment for JNJ.

The Coca-Cola Company (KO)

Beverage company KO manufactures, markets, and sells various non-alcoholic beverages worldwide. The company provides sparkling soft drinks, flavored and enhanced water, sports drinks, juice, dairy, plant-based beverages, tea, coffee, and energy drinks.

On October 25, 2022, James Quincey, KO’s Chairman and CEO, said, “Our business is resilient amidst a dynamic operating and macroeconomic environment. We are investing in our strong portfolio of brands, which is a cornerstone of our ability to deliver long-term value for our stakeholders.”

KO has paid dividends for 59 consecutive years. Its dividend payouts have increased at a 3.6% CAGR over the past five years. Its current dividend yield is 2.87%, while its four-year average yield is 3.08%.

KO’s net operating revenues came in at $11.06 billion for the third quarter ended September 30, 2022, up 10.2% year-over-year. Its net income came in at $2.83 billion, up 14.3% year-over-year, while its EPS came in at $0.65, up 14% year-over-year.

Street expects KO’s revenue to increase 10.5% year-over-year to $42.70 billion in 2022. Its EPS is expected to grow 6.9% year-over-year to $2.48 in 2022. The stock surpassed EPS estimates in all four trailing quarters. Over the past month, the stock has gained 12.6% to close the last trading session at $61.32.

KO’s overall B rating translates to a Buy in our proprietary rating system. It has a B grade for Stability, Sentiment, and Quality.

KO is ranked #20 out of 34 stocks within the A-rated Beverages industry. Click here for the additional POWR Ratings for KO (Growth, Value, Momentum).


JNJ shares were trading at $171.80 per share on Monday morning, up $2.55 (+1.51%). Year-to-date, JNJ has gained 2.40%, versus a -15.43% rise in the benchmark S&P 500 index during the same period.


About the Author: Riddhima Chakraborty


Riddhima is a financial journalist with a passion for analyzing financial instruments. With a master's degree in economics, she helps investors make informed investment decisions through her insightful commentaries. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
JNJGet RatingGet RatingGet Rating
KOGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

What is “Active Investing”?

Long term investing is not an easy path to top the stock market (SPY). On the other hand most active trading approaches miss some key elements that lead to outperformance. So let’s talk about a best of both worlds approach called “Active Investing”. Read on below for more...

:  |  News, Ratings, and Charts

The 5 Best Stocks to Invest in for the Long Term

Despite current market uncertainties, the U.S. economy's long-term growth prospects are pretty viable. Experts believe inflation will fall dramatically in the coming year, and robust growth will follow. Therefore, investors could buy quality stocks Microsoft (MSFT), Vertex Pharmaceuticals (VRTX), Centene (CNC), Agilent Technologies (A), and Myers Industries (MYE), which seem poised for steady long-term growth. Keep reading…

:  |  News, Ratings, and Charts

1 Chip Stock Warren Buffett Just Bought

Warren Buffet recently purchased shares of chip giant Taiwan Semiconductor (TSM) worth more than $4 billion. The company enjoys a leadership position in the field of advanced semiconductors. However, is it well-positioned to survive the economic and industry-specific challenges now? Read on to find out…

:  |  News, Ratings, and Charts

The 3 Most Stable Stocks to Buy in This Crazy Market

Even though the most recent inflation data shows signs of cooling down, the Fed will likely continue raising rates to meet its target. Moreover, the weakening profit outlook for the fourth quarter only adds to the recession worries. Hence, fundamentally strong and stable stocks PepsiCo (PEP), Cisco Systems (CSCO), and Sprouts Farmers Market (SFM) might be solid buys in this crazy scenario. Continue reading...

:  |  News, Ratings, and Charts

1 Chip Stock Warren Buffett Just Bought

Warren Buffet recently purchased shares of chip giant Taiwan Semiconductor (TSM) worth more than $4 billion. The company enjoys a leadership position in the field of advanced semiconductors. However, is it well-positioned to survive the economic and industry-specific challenges now? Read on to find out…

Read More Stories

More Johnson & Johnson (JNJ) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All JNJ News